Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.12−0.06 (-1.89%)
Close on Nov 18, 2026Market cap $777.47MP/E –Yield –
Ardelyx net income
Net income is the profit left for shareholders after every expense, interest and tax.
Ardelyx's net income for the twelve months ending Jun 30, 2026 was -$55.70M. For fiscal 2025 it was -$61.60M. The highest annual figure on record is -$3.21M in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$61.60M | – |
| FY2024 | Dec 31, 2024 | -$39.14M | – |
| FY2023 | Dec 31, 2023 | -$66.07M | – |
| FY2022 | Dec 31, 2022 | -$67.21M | – |
| FY2021 | Dec 31, 2021 | -$158.17M | – |
| FY2020 | Dec 31, 2020 | -$94.31M | – |
| FY2019 | Dec 31, 2019 | -$94.94M | – |
| FY2018 | Dec 31, 2018 | -$91.30M | – |
| FY2017 | Dec 31, 2017 | -$64.34M | – |
| FY2016 | Dec 31, 2016 | -$112.39M | – |
| FY2015 | Dec 31, 2015 | -$29.62M | – |
| FY2014 | Dec 31, 2014 | -$3.21M | – |
| FY2013 | Dec 31, 2013 | -$6.56M | – |
| FY2012 | Dec 31, 2012 | -$9.79M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$37.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$407.00K | -108.8% |
| Q3 FY2025 | Sep 30, 2025 | -$969.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.08M | – |
| Q1 FY2025 | Mar 31, 2025 | -$41.14M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$809.00K | -112.2% |
| Q2 FY2024 | Jun 30, 2024 | -$16.45M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.52M | – |
| Q4 FY2023 | Dec 31, 2023 | -$28.80M | -369.3% |
| Q3 FY2023 | Sep 30, 2023 | $6.63M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$26.77M | – |
| Q4 FY2022 | Dec 31, 2022 | $10.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$22.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$26.94M | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.07M | – |
| Q4 FY2021 | Dec 31, 2021 | -$36.23M | – |
| Q3 FY2021 | Sep 30, 2021 | -$43.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$45.19M | – |
| Q1 FY2021 | Mar 31, 2021 | -$33.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$28.88M | – |
| Q3 FY2020 | Sep 30, 2020 | -$18.11M | – |
| Q2 FY2020 | Jun 30, 2020 | -$24.96M | – |
| Q1 FY2020 | Mar 31, 2020 | -$22.37M | – |
| Q4 FY2019 | Dec 31, 2019 | -$19.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$23.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$25.47M | – |
| Q1 FY2019 | Mar 31, 2019 | -$26.14M | – |
| Q4 FY2018 | Dec 31, 2018 | -$27.86M | -375.5% |
| Q3 FY2018 | Sep 30, 2018 | -$24.13M | – |
| Q2 FY2018 | Jun 30, 2018 | -$22.29M | – |
| Q1 FY2018 | Mar 31, 2018 | -$17.02M | – |
| Q4 FY2017 | Dec 31, 2017 | $10.11M | – |
| Q3 FY2017 | Sep 30, 2017 | -$20.72M | – |
| Q2 FY2017 | Jun 30, 2017 | -$25.72M | – |
| Q1 FY2017 | Mar 31, 2017 | -$28.01M | – |
| Q4 FY2016 | Dec 31, 2016 | -$31.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$29.03M | – |
See a number that looks wrong?